REVA MEDICAL INC |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - AUD | -.--% |
|
-.--% | +13.33% |
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Tom Steinke
CEO | Chief Executive Officer | - | - |
| Chief Executive Officer | 57 | 11-02-24 | |
Jessica Earley
COO | Chief Operating Officer | - | 02-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 98-06-02 | |
Bernard E. Lyons
BRD | Director/Board Member | - | - |
Tamara Elias
BRD | Director/Board Member | 53 | 19-12-31 |
Rive Medical Inc, formerly known as, REVA Medical, LLC. is a United States-based medical device company. The Company is focused on the development of bioresorbable polymers for vascular applications. It provides a commercial polymer which is Tyrocore, which was invented for bioresorbable vascular scaffolds. Tyrocore is used to make Fantom Encore, a drug-eluting bioresorbable scaffold for the treatment of coronary artery disease.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.33% | 415K | |
| +2.64% | 208B | |
| +1.80% | 174B | |
| +8.59% | 130B | |
| +16.47% | 98.97B | |
| -3.42% | 60.46B | |
| +12.71% | 51.73B | |
| -6.61% | 45.33B | |
| -4.53% | 38.9B | |
| +9.27% | 38.56B |
- Stock Market
- Equities
- RVA Stock
